SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
EVOTEC AG
(NQPK:EVTCY Last Sale: 8.73 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (EVTCY : $8.73) (EVOTF : $3.48)
$517 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Schnackenburgallee 114 Research Report Earnings Snapshot - Last 05/14/17
Hamburg, 22525 Annual Reports
Germany
Phone: 49.(0)40.560 81-286

Mario Polywka, COO, Klaus Maleck, CFO
Specializes in finding new treatments for diseases of the Central Nervous System. Has four programs in clinical development: EVT 201, a partial positive allosteric modulator (pPAM) of the GABAA receptor complex for the treatment of insomnia, EVT 302, a MAO-B inhibitor in development for smoking cessation, EVT 101, a subtype selective NMDA receptor antagonist for the treatment of Alzheimer¿s disease and/or pain, and a P2X7 antagonist for the treatment of inflammatory diseases. Has a number of proprietary projects in preclinical development and a worldwide license agreement with Pfizer to research, develop and commercialize small molecule vanilloid receptor (VR1) antagonists for the treatment of pain.
Historical Charts    Technical Analysis
No Historical Data available for EVTCY
Historical Charts    Technical Analysis
No Historical Data available for EVOTF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common EVTCY $8.73 $ 0 $8.693 $8.749 2,254 $5.38 $8.749 59,236
Common EVOTF $3.48 $ 0 $3.48 $3.53 1,600 $2.79 $3.9353 0
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $517,130

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex